A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

BACKGROUND: A considerable number of children with asthma remain symptomatic despite treatment with inhaled corticosteroids, resulting in significant morbidity, reduced quality of life, increased healthcare costs and lost school days. The aim of our study was to assess the efficacy, safety and toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelberg, Christian, Moroni-Zentgraf, Petra, Leonaviciute-Klimantaviciene, Migle, Sigmund, Ralf, Hamelmann, Eckard, Engel, Michael, Szefler, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331449/
https://www.ncbi.nlm.nih.gov/pubmed/25851298
http://dx.doi.org/10.1186/s12931-015-0175-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331449/
https://www.ncbi.nlm.nih.gov/pubmed/25851298
http://dx.doi.org/10.1186/s12931-015-0175-9

Ejemplares similares